NCT04626440

Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools

Comprehensive Precision Medicine Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,875 (estimated)
• Sponsor: vghtpe user · Other Government
• Sex: Female
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The objectives of this study are: 1. To determine the difference in genetic profiling of subjects with breast cancer recurrence 2. To determine the comprehensive genetic profiling of subjects with late stage breast cancer 3. To determine the potential biomarkers for early detection and prognosis for breast cancer 4. To determine the genetic profiling of immune system in different subtypes of breast cancer By integrating and analyzing the data generated using the methods of NGS, these information can be used for: 1. Understanding the genetic profiling of different subtypes of breast cancer in Taiwan 2. Assessing the efficacy of different treatments in breast cancer subjects 3. Defining the molecular risk factors and predicting the potential risk of breast cancer recurrence 4. Assessing the immune repertoire and the potential effects of immunotherapy in breast cancer subjects 5. Developing new strategies in treating patients with triple negative or late stage of breast cancer

Conditions

• Next Generation Sequencing (NGS)
• Breast Cancer

Interventions

Type	Name	Description
PROCEDURE	Diagnostic stage or the Clinical outcome	After enrollment, individual subject will be assigned into one of the four groups according to the medical management received, the diagnostic stage of breast cancer (BC), or the clinical outcome of BC at enrollment.

Timeline

• Start date: 2018-11-22
• Primary completion: 2026-08-31
• Completion: 2026-08-31
• First posted: 2020-11-12
• Last updated: 2020-11-12

Locations

1 site across 1 country: Taiwan